NCT07765927 Exercise Oncology Clinic Pilot Feasibility Trial
| NCT ID | NCT07765927 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jess S. Gorzelitz |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-08-03 |
| Primary Completion | 2026-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-08-03 with a primary completion date of 2026-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this pilot study is to test a supervised exercise program for adults with a history of breast or gynecologic cancer to see if it is safe, helpful, and easy to take part in.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Confirmed diagnosis of breast or gynecologic cancer (any stage) * Willingness to participate in the exercise oncology program and associated research procedures Ability to provide informed consent * Clearance to participate in exercise as determined by completion of the Physical Activity Readiness Questionnaire Plus (PAR-Q+) and any additional clinical screening as needed Exclusion Criteria: * Presence of absolute contraindications to exercise (e.g., unstable cardiovascular disease, acute illness, or other conditions that preclude safe participation in physical activity) * Determination by a referring or treating healthcare provider that the patient is not appropriate for exercise participation at the time of screening * Inability to complete required screening procedures, including the PAR-Q+
Contact & Investigator
Jess Gorzelitz, PhD, MS
PRINCIPAL INVESTIGATOR
University of Iowa
Frequently Asked Questions
Who can join the NCT07765927 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07765927 currently recruiting?
Yes, NCT07765927 is actively recruiting participants. Contact the research team at jessica-gorzelitz@uiowa.edu for enrollment information.
Where is the NCT07765927 trial being conducted?
This trial is being conducted at Iowa City, United States.
Who is sponsoring the NCT07765927 clinical trial?
NCT07765927 is sponsored by Jess S. Gorzelitz. The principal investigator is Jess Gorzelitz, PhD, MS at University of Iowa. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.